Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Sinocelltech to conduct phase I study of anti-EGFR antibody in patients with colorectal cancer

Aug. 21, 2014

Altor BioScience receives NCI grant to support bladder cancer trial

Aug. 20, 2014

Preclinical data on novel anti-human CCR9 MAb for leukemia

Aug. 20, 2014

Seattle Genetics begins phase I study of SGN-CD70A

Aug. 14, 2014

TapImmune confirms new clinical trial of folate receptor alpha peptide antigens

Aug. 12, 2014

Genetic modification of T-cell epitopes in therapeutic toxins to minimize immunogenic reactions

Aug. 11, 2014

Sym-004 advances into two new trials

Aug. 8, 2014

Regen BioPharma advances development of dCellVax

Aug. 6, 2014

GSK and Genmab report interim data for phase III study of ofatumumab in relapsed CLL

Aug. 5, 2014

Researchers at Xencor divulge new heterodimeric proteins

Aug. 4, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...